We are live on ! Find out more
TS

Triglav Skladi Portfolio holdings

AUM $1.43B
1-Year Est. Return 39.24%
This Fund
S&P 500
This Quarter Est. Return
+11.31%
1 Year Est. Return
+39.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.53B
AUM Growth
+$145M
Cap. Flow
+$16.9M
Cap. Flow %
1.11%
Top 10 Hldgs %
51.73%
Holding
148
New
17
Increased
53
Reduced
21
Closed
8

Top Buys

Rank Stock Value
1
APH icon
Amphenol
APH
+$9.03M
2
AAPL icon
Apple
AAPL
+$7.75M
3
GS icon
Goldman Sachs
GS
+$7.33M
4
WFC icon
Wells Fargo
WFC
+$6.33M
5
TSM icon
TSMC
TSM
+$5.87M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$14M
2
TFC icon
Truist Financial
TFC
+$9.39M
3
V icon
Visa
V
+$8.45M
4
DE icon
Deere & Co
DE
+$8.17M
5
NFLX icon
Netflix
NFLX
+$7.79M

Sector Composition

Rank Sector Weight
1 Technology 40.15%
2 Communication Services 14.02%
3 Financials 13.17%
4 Consumer Discretionary 12.39%
5 Healthcare 11.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
76
Intuitive Surgical
ISRG
$133B
$2.02M 0.13%
4,520
-3,500
-44% -$1.68M
IBN icon
77
ICICI Bank
IBN
$108B
$1.92M 0.13%
63,372
ZTS icon
78
Zoetis
ZTS
$30.8B
$1.9M 0.12%
13,000
APP icon
79
Applovin
APP
$115B
$1.8M 0.12%
+2,500
New +$1.15M
GILD icon
80
Gilead Sciences
GILD
$165B
$1.78M 0.12%
16,000
DELL icon
81
Dell
DELL
$286B
$1.7M 0.11%
12,000
+1,500
+14% +$195K
REGN icon
82
Regeneron Pharmaceuticals
REGN
$80.4B
$1.69M 0.11%
3,000
+485
+19% +$274K
MRVL icon
83
Marvell Technology
MRVL
$195B
$1.68M 0.11%
20,000
UTHR icon
84
United Therapeutics
UTHR
$22.7B
$1.68M 0.11%
4,000
HDB icon
85
HDFC Bank
HDB
$121B
$1.67M 0.11%
49,000
ELV icon
86
Elevance Health
ELV
$85B
$1.61M 0.11%
4,980
EW icon
87
Edwards Lifesciences
EW
$51.6B
$1.56M 0.1%
20,060
NBIX icon
88
Neurocrine Biosciences
NBIX
$16.6B
$1.54M 0.1%
11,000
ACN icon
89
Accenture
ACN
$106B
$1.54M 0.1%
6,250
DE icon
90
Deere & Co
DE
$169B
$1.48M 0.1%
3,239
-16,570
-84% -$8.17M
SCHW
91
Charles Schwab
SCHW
$186B
$1.43M 0.09%
+15,000
New +$1.42M
HOOD icon
92
Robinhood
HOOD
$84B
$1.43M 0.09%
+10,000
New +$1.09M
VRTX icon
93
Vertex Pharmaceuticals
VRTX
$124B
$1.35M 0.09%
3,450
FDX icon
94
FedEx
FDX
$75.3B
$1.34M 0.09%
5,704
+44
+0.8% +$10.1K
COF icon
95
Capital One
COF
$133B
$1.34M 0.09%
+6,300
New +$1.38M
SPGI icon
96
S&P Global
SPGI
$121B
$1.34M 0.09%
2,750
AVY icon
97
Avery Dennison
AVY
$13.4B
$1.29M 0.08%
7,980
-29,770
-79% -$5.13M
NET icon
98
Cloudflare
NET
$109B
$1.29M 0.08%
6,000
AMGN icon
99
Amgen
AMGN
$220B
$1.27M 0.08%
4,500
DXCM icon
100
DexCom
DXCM
$31.8B
$1.24M 0.08%
18,500

Similar funds

Triglav Skladi's Q3 2025 Portfolio in Review

As of Q3 2025, Triglav Skladi held 148 positions worth $1.53B, up 11% from $1.38B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Triglav Skladi's Q3 2025 filing shows 17 new, 53 increased, 21 reduced and 8 closed positions. Its largest new stake was Amphenol: 82,300 shares worth $10.2M. The largest sale was Broadcom, an estimated $14M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Communication Services and Financials.

  • Triglav Skladi's largest Q3 2025 buy was Amphenol: 82,300 shares worth $10.2M.
  • Triglav Skladi added most to Apple in Q3 2025, an estimated $7.75M increase.
  • Triglav Skladi's biggest Q3 2025 reduction was Broadcom, cutting an estimated $14M.
  • Triglav Skladi fully exited Truist Financial in Q3 2025, selling an estimated $9.39M.
  • Triglav Skladi's ten largest holdings make up 52% of its $1.53B portfolio in Q3 2025.
  • Triglav Skladi opened 17 new positions and closed 8 in Q3 2025.
  • Triglav Skladi's portfolio value rose 11% quarter-over-quarter to $1.53B.

Based on Triglav Skladi's 13F filing for Q3 2025, filed 5 Nov 2025.